Induction of IP-10/CXCL10 secretion as an immunomodulatory effect of low-dose adjuvant interferon-alpha during treatment of melanoma.
Immunobiology. 2010;215(2):113-23. doi: 10.1016/j.imbio.2009.03.008. Epub 2009 May 17.
Immunobiology. 2010.
PMID: 19450896
Clinical Trial.